GlassScriptPhysician profile
Melanie Goodwin
NPI 1902357858
$4,878.94
in general payments reported to CMS, 2019-2025
44 companies · $314 in 2025
The $314 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,630 · 2022: $1,086 · 2023: $1,258 · 2024: $592 · 2025: $314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,163.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $976.88 | 2021 | |
| Novo Nordisk INC | $611.82 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $502.65 | 2021-2024 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $305.77 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $290.38 | 2022-2025 | Farxiga, Breztri, Airsupra |
| Pfizer INC. | $285.75 | 2022-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $218.03 | 2021-2023 | Xifaxan |
| Amgen INC. | $157.68 | 2021-2024 | Repatha, Otezla |
| Glaxosmithkline, LLC. | $123.76 | 2022-2023 | Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $119.89 | 2021-2023 | Jardiance |
| Bausch Health US, LLC | $113.18 | 2022-2024 | Aplenzin, Wellbutrin |
| Bayer Healthcare Pharmaceuticals INC. | $89.86 | 2023-2025 | |
| Exact Sciences Corporation | $74.59 | 2023-2024 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $70.03 | 2021-2023 | Rexulti |
| Novartis Pharmaceuticals Corporation | $69.83 | 2021-2023 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Goodwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.